Difference in Incontinence Prevalence Between High Impact Athletes, Low Impact Athletes and Sedentary Subjects

NCT07710508 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2026-07-23

No results posted yet for this study

Summary

This observational cross-sectional study aims to investigate the association between participation in high-impact sports, physical activity level, and urinary incontinence in young adults. The study will compare six groups based on sex and physical activity level: male and female high-impact sports participants, physically active males and females who do not participate in high-impact sports, and sedentary males and females.

Participants aged 18-35 years will undergo a single assessment including sociodemographic and medical information, physical activity assessment, urinary incontinence questionnaires, sport-related characteristics, psychosocial questions regarding the influence of social taboos on questionnaire responses, lower-limb muscle strength testing using a load cell, and vertical jump performance assessment.

The study aims to describe the prevalence, severity, type, and impact of urinary incontinence across different activity levels and sexes, and to explore potential associations with lower-limb strength, jump performance, and sport-related characteristics.

Conditions

  • Urinary Incontinence (UI)
  • Urinary Incontinence , Stress

Interventions

DIAGNOSTIC_TEST

No Intervention: Observational Cohort

No intervention

Sponsors & Collaborators

  • University of Valencia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-24
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07710508 on ClinicalTrials.gov